89Zr-Trop2 ARC

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug Name89Zr-Trop2 ARC

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionAnti-Trop-2

TargetsTumor-associated calcium signal transducer 2

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHoneyBear Biosciences Inc University Of California San Francisco

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San Francisco HoneyBear Biosciences Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A